Blueprint Medicines Corp(BPMC)
$107.19▲0.18%
Market is closed - opens 7 PM, 06 May 2024
Insights
- Blueprint Medicines Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Blueprint Medicines Corp stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Blueprint Medicines Corp stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Blueprint Medicines Corp stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 72.5 | Sell |
Stochastic | 85.88, 86.96 | Sell |
Ultimate Oscillator | 59.11 | Neutral |
Stochastic Relative Strength Index | 100.0, 94.08 | Neutral |
Moving Average Convergence Divergence | 2.89, 1.14 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 95.24 | Buy |
20 | 92.08 | Buy |
50 | 91.67 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 96.89 | Buy |
20 | 93.98 | Buy |
50 | 90.85 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 97.15 | Buy |
20 | 93.86 | Buy |
50 | 92.41 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 101.41 | Buy |
20 | 97.25 | Buy |
50 | 94.84 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 104.36 | Buy |
20 | 99.5 | Buy |
50 | 95.5 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 120.39 |
Resistance L2 | 115.27 |
Resistance L1 | 111.14 |
Pivot Point | 106.02 |
Support L1 | 101.88 |
Support L2 | 96.77 |
Support L3 | 92.63 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.